LABORATORY NEWS
-
Abbott Launches SimpleScreen™ CRC Blood Test, Joining Cologuard Plus® In Its Colorectal Cancer Screening Portfolio
Abbott (NYSE: ABT) today announced the U.S. commercial launch of SimpleScreen™ CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average risk for the disease.
- NovoPath Comes To Market With The Next-Generation LIS That Has The Digital Pathology Workflow Built In. One Platform, One Workflow, One Source Of Truth For Pathologists, The Lab, And The Business
- EpiSign Launches METRIC 5-Base, Enabling Comprehensive Episignature Analysis Across Genome-Sequencing Platforms
- Roche Launches Newborn Screening Test For Three Severe Genetic Conditions
- Caris Life Sciences Unveils The Next Evolution Of Liquid Biopsy With Enhanced Caris Assure
ARCHIVED NEWSLETTER
- 09.22.26 -- Sakura Finetek Europe Launches Sakura Pathology Network
- 08.25.26 -- GHK-Cu Peptide Launched By Kylo Peptides For Laboratory Research Applications
- 07.21.26 -- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics